A detailed history of Black Rock Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,351,054 shares of ASRT stock, worth $6.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,351,054
Previous 6,574,483 3.4%
Holding current value
$6.8 Million
Previous $7.03 Million 13.32%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.79 - $1.14 $176,508 - $254,709
-223,429 Reduced 3.4%
6,351,054 $6.1 Million
Q4 2023

Feb 13, 2024

BUY
$1.02 - $2.57 $643,744 - $1.62 Million
631,122 Added 10.62%
6,574,483 $7.03 Million
Q3 2023

Nov 13, 2023

BUY
$2.52 - $5.69 $5.19 Million - $11.7 Million
2,061,114 Added 53.09%
5,943,361 $15.2 Million
Q2 2023

Aug 11, 2023

BUY
$5.0 - $7.66 $14.6 Million - $22.4 Million
2,918,194 Added 302.7%
3,882,247 $21 Million
Q1 2023

May 12, 2023

BUY
$3.54 - $6.66 $110,759 - $208,378
31,288 Added 3.35%
964,053 $6.14 Million
Q4 2022

Feb 13, 2023

BUY
$2.48 - $4.3 $100,492 - $174,240
40,521 Added 4.54%
932,765 $4.01 Million
Q3 2022

Nov 14, 2022

SELL
$2.13 - $4.0 $4,698 - $8,824
-2,206 Reduced 0.25%
892,244 $2.02 Million
Q2 2022

Aug 12, 2022

BUY
$1.88 - $3.42 $194,645 - $354,089
103,535 Added 13.09%
894,450 $2.64 Million
Q1 2022

May 12, 2022

BUY
$2.06 - $3.0 $7,817 - $11,385
3,795 Added 0.48%
790,915 $2.27 Million
Q4 2021

Feb 10, 2022

BUY
$0.86 - $2.3 $3,192 - $8,537
3,712 Added 0.47%
787,120 $1.72 Million
Q3 2021

Nov 09, 2021

BUY
$0.89 - $1.55 $851 - $1,483
957 Added 0.12%
783,408 $709,000
Q2 2021

Aug 11, 2021

BUY
$1.48 - $2.88 $1.16 Million - $2.25 Million
782,451 New
782,451 $1.22 Million

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $51.6M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.